InnoSIGN

About:

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.

Website: https://www.innosignbio.com/

Top Investors: Casdin Capital, Life Science Angels, Thuja Capital, Brabant Development

Description:

InnoSIGN is an mRNA-based pathway activity profiling technique that aims to transform precision medicine by providing greater insight into disease causes. The company proposes to use its enormous library of pathway activity profiles to enhance diagnostics and drug discovery, giving researchers with qPCR tests for decentralized use through a service testing facility in the Netherlands.